INT313043

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.21
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.13
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cell proliferation (MAS1) plasma membrane (MAS1) signal transducer activity (MAS1)
MAS1 (Homo sapiens)
Pain Link Frequency Relevance Heat
drug abuse 3 24.72 Low Low
Central nervous system 1 22.56 Low Low
abdominal pain 5 5.00 Very Low Very Low Very Low
headache 4 5.00 Very Low Very Low Very Low
withdrawal 1 5.00 Very Low Very Low Very Low
Angina 1 5.00 Very Low Very Low Very Low
Bioavailability 1 5.00 Very Low Very Low Very Low
addiction 1 5.00 Very Low Very Low Very Low
Neurobehavioral 1 5.00 Very Low Very Low Very Low
tolerance 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Attention Deficit Hyperactivity Disorder 43 79.92 Quite High
Convulsion 1 31.36 Quite Low
Congenital Anomalies 1 26.80 Quite Low
Drug Dependence 4 24.72 Low Low
Hypersensitivity 2 18.80 Low Low
Thyroid Disease 3 16.64 Low Low
Tourette's Syndrome 1 15.28 Low Low
Sleep Disorders 6 5.00 Very Low Very Low Very Low
Abdominal Pain 5 5.00 Very Low Very Low Very Low
Vomiting 4 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
LDX doses of 30, 50, and 70 mg are equivalent in base content of d-amphetamine to extended-release MAS XR doses of 10, 20, and 30 mg, respectively.15 Doses greater than 70 mg/day have not been studied in children or adults.


Localization (release) of MAS XR
1) Confidence 0.21 Published 2010 Journal Neuropsychiatric Disease and Treatment Section Body Doc Link PMC2877609 Disease Relevance 0.13 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox